Exscientia
elucidate phase ongoing in advanced solid | Exscientia
Company
Deck Type
Sector
Industry
Deck date
March 2024
Slide
49 of 93
Similar slides by Exscientia
See diffirences between slides (animation)
Results
March 2024
elucidate phase ongoing in advanced solid | Exscientia
Investor Day
January 2024
elucidate phase ongoing in advanced solid | Exscientia
Investor Presentation
November 2023
elucidate phase ongoing in advanced solid | Exscientia
Investor Presentation
October 2023
elucidate phase ongoing in advanced solid | Exscientia
Related slides by other companies
Nuvalent
Investor Presentation
February 2024
the path to patient impact program status first approved a toe pivotal data naive and study for phase ongoing with registrational intent for patients with execute on global registrational strategies additional discovery research programs ongoing product mission bringing new best in class medicines to patients with cancer treated alk planned development in naive setting phase ongoing with registrational intent for patients with study for alk planned phase initiation in for her | Nuvalent
BioAtla
Investor Presentation
January 2024
cab phase dose titration ongoing | BioAtla
Arbutus Biopharma
Investor Presentation
March 2023
phase a clinical trial | Arbutus Biopharma
Arbutus Biopharma
Investor Presentation
May 2023
phase a clinical trial | Arbutus Biopharma
Other recent decks by Exscientia
See all presentations (14 decks)
Results
March 2024
Investor Day
January 2024
Investor Presentation
November 2023
Results
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io